ARTHRITIS DRUGS ADVISORY COMMITTEE
August 16, 2001
Kineret™ (anakinra)
(Recombinant Methionyl Human Interleukin-1 Receptor Antagonist)
Briefing Information
Amgen Inc
Disclaimer
The statements contained in this document are those of the product's sponsor, not FDA, and FDA does not necessarily agree with the sponsor's statements. FDA has not made a final determination about the safety or effectiveness of the product described in this document.
Food and Drug Administration